Does the dose-solubility ratio affect the mean dissolution time of drugs?
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Models, Chemical * MeSH
- Pharmaceutical Preparations administration & dosage chemistry MeSH
- Solubility MeSH
- Capsules MeSH
- Water chemistry MeSH
- Dose-Response Relationship, Drug MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Pharmaceutical Preparations MeSH
- Capsules MeSH
- Water MeSH
PURPOSE: To present a new model for describing drug dissolution. On the basis of the new model to characterize the dissolution profile by the distribution function of the random dissolution time of a drug molecule, which generalizes the classical first order model. METHODS: Instead of assuming a constant fractional dissolution rate, as in the classical model, it is considered that the fractional dissolution rate is a decreasing function of the dissolved amount controlled by the dose-solubility ratio. The differential equation derived from this assumption is solved and the distribution measures (half-dissolution time, mean dissolution time, relative dispersion of the dissolution time, dissolution time density, and fractional dissolution rate) are calculated. Finally, instead of monotonically decreasing the fractional dissolution rate, a generalization resulting in zero dissolution rate at time origin is introduced. RESULTS: The behavior of the model is divided into two regions defined by q, the ratio of the dose to the solubility level: q < 1 (complete dissolution of the dose, dissolution time) and q > 1 (saturation of the solution, saturation time). The singular case q = 1 is also treated and in this situation the mean as well as the relative dispersion of the dissolution time increase to infinity. The model was successfully fitted to data (1). CONCLUSIONS: This empirical model is descriptive without detailed physical reasoning behind its derivation. According to the model, the mean dissolution time is affected by the dose-solubility ratio. Although this prediction appears to be in accordance with preliminary application, further validation based on more suitable experimental data is required.
See more in PubMed
J Pharm Sci. 1997 Nov;86(11):1245-9 PubMed
Pharm Res. 1996 Dec;13(12):1799-803 PubMed
J Pharmacokinet Biopharm. 1986 Dec;14(6):635-57 PubMed
Pharm Res. 1995 Mar;12(3):413-20 PubMed
Pharm Res. 1997 Sep;14(9):1122-6 PubMed
Pharm Res. 1993 Feb;10(2):264-70 PubMed
Modeling heterogeneity of properties and random effects in drug dissolution
